XML 23 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Assets    
Cash and cash equivalents $ 188,657 $ 114,846
Investment securities, available-for-sale 250,208 301,977
Accounts receivable, net 98,267 62,195
Interest and other receivables 4,083 885
Inventory 35,819 6,636
Prepaid expenses 39,091 21,398
Total current assets 616,125 507,937
Property and equipment, net 4,612 6,021
Operating lease right-of-use assets 51,855 55,573
Intangible assets, net 65,490 0
Restricted cash 5,770 5,770
Long-term inventory 4,628 4,924
Other assets 476 7,587
Total assets 748,956 587,812
Liabilities and stockholders’ equity    
Accounts payable 17,543 12,746
Accrued liabilities 236,711 112,884
Total current liabilities 254,254 125,630
Operating lease liabilities 47,800 52,695
Other long-term liabilities 15,147 9,074
Total liabilities 317,201 187,399
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at December 31, 2023 and 2022; 164,650,219 shares and 162,064,872 shares issued and outstanding at December 31, 2023 and 2022, respectively 16 16
Additional paid-in capital 2,862,552 2,770,923
Accumulated deficit (2,430,837) (2,369,551)
Accumulated other comprehensive income (loss) 24 (975)
Total stockholders’ equity 431,755 400,413
Total liabilities and stockholders’ equity $ 748,956 $ 587,812